Bipolar disorder affects over 2% of the population and has a serious impact on the lives of those who suffer from this. The CIBERSAM programme for research into this illness is one of the world leaders in identification of the causes and treatment of bipolar disorder. It is making a substantial contribution to improving its prognosis, both through pharmacotherapy and through innovative psychological interventions. The research done by the CIBERSAM has allowed us to identify the risk genes, cerebral circuits involved in emotional dysregulation, biomarkers and the psychosocial triggering factors involved in the appearance of this disorder, which will in the future, with the required economic support, enable us to get increasingly closer to the objective of curing and effectively preventing the illness.
|Main Researcher||Consortium Institution||Regions||Details|
|Peter J. Mckenna||Hospital Hermanas Hospitalarias Benito Menni||Cataluña||View group|
|Eduard Vieta Pascual||Hospital Clinico y Provincial de Barcelona||Cataluña||View group|
|Rafael Tabares Seisdedos||Universidad de Valencia. Facultad de Medicina||C. Valenciana||View group|
|Ana González-Pinto Arrillaga||Hospital Universitario de Álava||País Vasco||View group|
|Julio Bobes García||Universidad de Oviedo. Facultad de Medicina||Asturias||View group|
|José Luis Ayuso Mateos||Hospital Universitario La Princesa||Madrid||View group|